The Carlat Psychiatry Podcast podcast

ProLivRx: A New Approval in Depression

0:00
20:50
Manda indietro di 15 secondi
Manda avanti di 15 secondi

We interview Linda Carpenter, lead investigator on the new FDA approved device for difficult-to-treat depression.

CME: Take the CME Post-Test for this Episode

Published On: 01/19/2026

Duration: 20 minutes, 49 seconds

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Altri episodi di "The Carlat Psychiatry Podcast"